Professor Gokhan Hotamisligil Receives 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence
- Written by Admin TOA
- Published in Academicians
Turkish American Professor Gokhan S. Hotamisligil received the 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence for his outstanding research efforts that have led to groundbreaking new knowledge about the relationship between obesity and diabetes and potential paths for treatment.
Professor Hotamisligil is a Turkish American physician scientist; James Stevens Simmons Professor of Genetics and Metabolism; chair of the Department of Genetics and Complex Diseases at Harvard T.H. Chan School of Public Health (HSPH); director of the Sabri Ulker Center for Metabolic Research and associate member of Harvard-MIT Broad Institute, Harvard Stem Cell Institute and the Joslin Diabetes Center.
The Prize is awarded in collaboration between the European Association for the Study of Diabetes (EASD) and the Novo Nordisk Foundation to recognize outstanding research or technology contributions to the understanding of diabetes, its disease mechanisms or its complications. The Prize is accompanied by DKK 6 million (approximately one million U.S. dollars) for personal and research purposes.
Last modified onWednesday, 19 September 2018 22:41
Tagged under
Related items
Latest from Admin TOA
- 300 migrants to be housed at shuttered Catholic church on Northwest Side in Chicago
- Turkish Stand-Up Sensation Hasan Can Kaya Embarks on U.S. Tour with Art Evi Production, in212 Production, and TAAS New York
- "Lean Startup, To Lean Company, To Rich Exit" by Dr. Kenan Sahin is released with Forbes Books
- LOSEV USA Ramadan Campaign Let the Children Heal First with Your Ramadan Donations
- Azerbaijan Society of America Honors Centennial Anniversary of the Great Azerbaijani Politician the National Leader of Azerbaijan President Heydar Aliyev